Nathan J Dowden insider trades

Open-market stock purchases and sales by Nathan J Dowden, President & COO at Entrada Therapeutics, Inc, from SEC Form 4 filings since Oct 28, 2021.

Recent trades

DateStockTradeValue
Sep 2, 2026TRDA Entrada Therapeutics, IncSold (not open market)$18.1K
May 4, 2026TRDA Entrada Therapeutics, IncSold$230K
May 4, 2026TRDA Entrada Therapeutics, IncBought (not open market)—
Mar 10, 2026TRDA Entrada Therapeutics, IncSold$155K
Mar 9, 2026TRDA Entrada Therapeutics, IncSold$40.6K
Mar 3, 2026TRDA Entrada Therapeutics, IncSold (not open market)$165K
Mar 2, 2026TRDA Entrada Therapeutics, IncSold (not open market)$84.2K
Mar 1, 2026TRDA Entrada Therapeutics, IncBought (not open market)—
Mar 1, 2026TRDA Entrada Therapeutics, IncBought (not open market)—

Companies traded

  • TRDA Entrada Therapeutics, Inc: 31 sales, last Sep 2, 2026

Get free alerts when Nathan J Dowden files a new trade →